Companies/US/DNLI

DENALI THERAPEUTICS INC.

Last · NASDAQ$17.87-0.53 (-2.88%)close · yahoo · 16h ago
Vol 2.70M ≈ 48.31M
Market cap$2.86B159.8M sh
P/E · TTM-6.3fwd -7.4 · eps -2.84 · loss
Beta1.02vs S&P 500
Div yield0.00%annual · TTM
52w range
$13.75$27.30
Volume2.7Msession

Issuer

Legal nameDENALI THERAPEUTICS INC.
HQUnited States (US)
ListingUS DNLI
ISINUS24823R1059
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001714899
CIK0001714899
Employees507
AddressDenali Therapeutics, Inc. 161 Oyster Point Boulevard 94080, San Francisco +650 866 8547
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-02-26

From latest 10-K · 2026-02-26

  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -43.9%
  • Cash Runway Low — Cash runway ~0.5 years
  • Accumulated Deficit High — Accumulated deficit / equity 202%

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.37
Est. revenue
22.9M

Earnings transcripts

1 recent

Documents

FormReporting forFiledFlags
2026-09-042026-09-090
2026-09-022026-09-040
2026-09-012026-09-030
2026-08-122026-08-140
2026-08-112026-08-130